What Sapyen does

Sapyen (legally Vito Health Pty Ltd, an Australian proprietary limited company) is a direct-to-consumer fertility diagnostics company that sells at-home male fertility test kits which are mailed to certified laboratories for analysis. Its product suite spans a Core Semen Analysis ($149), Antisperm Antibody Test ($229), DNA Fragmentation Test ($399), SpermEGT DNA Methylation Test ($529) integrating Path Fertility's SpermQT epigenetic assay, and a bundled Sapyen Complete Analysis ($869), plus Post-Vasectomy ($99) and Vasectomy Reversal tests and a Cryopreservation service. The core technical differentiator is its patent-pending SPX72 preservation fluid, which extends sperm sample viability to approximately 72 hours versus the industry standard of 60-90 minutes, enabling mail-in testing without sacrificing diagnostic accuracy.

The business operates a product-led DTC e-commerce model on its Shopify storefront across 25+ countries, supplemented by a B2B motion through referrals from IVF clinic networks (Genea, No.1 Fertility, IVIRMA, Adora Fertility, City Fertility) and employer fertility benefit integrations with Progyny, WIN Fertility, Maven Clinic and Carrot Fertility. Sapyen holds FDA, TGA, CE and MHRA registrations and operates through CLIA, UKAS, NATA and ISO 15189 accredited laboratories, with HIPAA, GDPR and Australian Privacy Act compliance. The company originated in Melbourne and expanded to the UK with an HFEA-licensed cryopreservation storage center.

Sapyen is privately held with no disclosed institutional funding beyond approximately $152,792 in early-stage capital from Antler and the Melbourne Accelerator Program. The customer base consists of men planning families, post-vasectomy patients, proactive fertility preservation users, couples undergoing fertility treatment, and healthcare professionals, served across North America, Europe, Asia-Pacific and the Middle East with multi-language instructions in 11 languages.

Name

Sapyen

Legal name

Vito Health Pty Ltd

Website

https://sapyen.co

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Sapyen (Vito Health Pty Ltd) is an Australia-founded fertility diagnostics company that sells at-home male fertility test kits using its patent-pending SPX72 72-hour preservation fluid, shipping directly to consumers in 25+ countries and via IVF clinic referrals and employer fertility benefits.

Ownership category

akta.pro rank

Product category

Fertility Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Testing Laboratories and Services (54138)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

akta.pro secondary industry

Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC) (HLAMANAJ)

Keywords

• At-home fertility testing
• Male fertility diagnostics
• Semen analysis kits
• Sperm cryopreservation services
• Fertility health platform

Headquarters

HQ city

Carlton

HQ country

Australia

HQ region

Oceania

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Direct Test Kit Sales: One-time purchase revenue from selling at-home male fertility test kits directly to consumers through the Sapyen e-commerce website. Products include Core Semen Analysis, DNA Fragmentation Test, Antisperm Antibody Test, SpermEGT DNA Methylation Test, Post-Vasectomy Semen Analysis, and Vasectomy Reversal tests.
2. Cryopreservation Services: Sperm freezing and storage services offered as an add-on to test kits. Customers pay $1 for first year storage (90-day program) with 6-year storage terms. Revenue generated from the cryopreservation program enrollment and ongoing storage fees.
3. Employer Fertility Benefits: Partnerships with fertility benefit providers Progyny and WIN Fertility where eligible members receive test kits at $0 out-of-pocket cost. Sapyen processes authorization requests and ships kits, with reimbursement coming from employer benefit plans.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Sapyen sells at-home male fertility diagnostic kits and an associated sperm cryopreservation service that allow men to collect semen samples privately at home, preserve them for up to 72 hours via the company's patent-pending SPX72 fluid, and mail them to certified laboratories (CLIA, NATA, UKAS, ISO 15189) for clinical-grade analysis. The test menu includes the Core Semen Analysis ($149), Antisperm Antibody Test ($229), DNA Fragmentation Test ($399), SpermEGT DNA Methylation Test ($529, integrated with Path Fertility's SpermQT epigenetic assay), bundled Sapyen Complete Analysis ($869), Post-Vasectomy Semen Analysis ($99), and Vasectomy Reversal Test ($149). Sapyen also sells a 90-day Cryopreservation program ($1 first-year storage with 6-year term at -196°C) and a Full Female Blood Panel for couples testing.

Product overview

Sapyen offers a suite of at-home male fertility diagnostic kits and services. The core product is the Core Semen Analysis kit ($149), which measures 12 sperm parameters including count, motility, morphology, and volume. Advanced add-on tests include the Antisperm Antibody Test ($229), DNA Fragmentation Test ($399), and SpermEGT DNA Methylation Test ($529). The Sapyen Complete Analysis ($869) bundles all tests into one comprehensive kit. Supporting services include Post Vasectomy Semen Analysis ($99), Vasectomy Reversal testing, and Sapyen Cryopreservation for sperm freezing ($1 first year storage). The company also offers a Full Female Blood Panel for couples testing. All tests use the proprietary patent-pending SPX72 preservation technology enabling 72-hour sample viability for mail-in testing.

Differentiator

Problem solved

Functional benefit

Brands

• SpermEGT: Epigenetic sperm DNA methylation test using SpermQT assay from Path Fertility, measuring sperm's ability to find, bind, penetrate, and fertilize an egg
• Sapyen Complete Analysis
• SPX72

Products and services

• Core Semen Analysis (Sapyen At-Home Male Fertility Analysis Kit) At-home semen analysis kit measuring sperm count, concentration, motility, morphology, volume, and other key parameters via the WHO 2021 standard (12 parameters). Sample is collected at home, preserved using SPX72 fluid for up to 72 hours, mailed to a certified lab, and clinical-grade results returned within 72 hours of lab receipt. Priced at $149 USD versus typical $250–$400 in-clinic costs. Targets individual men planning a family or evaluating fertility.
• Antisperm Antibody Test (Advanced At-Home Male Fertility Analysis Kit) Enhanced analysis adding antisperm antibody testing to the core semen parameters. Antisperm antibodies can halve fertilization rates even with IVF/ICSI, making this test relevant for immune-related infertility workups. Priced at $229 USD versus typical $300 in-clinic cost. Marketed for men with unexplained infertility or IVF/ICSI failure history.
• DNA Fragmentation Test (Semen Analysis and DNA Fragmentation Test Kit) Core semen analysis combined with DNA Fragmentation Index testing to assess genetic integrity of sperm and reveal quality issues that impact conception and pregnancy outcomes even when standard semen parameters appear normal. Priced at $399 USD versus typical $500 in-clinic cost, with results within 10 business days. Targets couples with recurrent pregnancy loss or unexplained infertility.
• SpermEGT DNA Methylation Test Epigenetic assay combining Core Semen Analysis with the SpermQT epigenetic assay from Path Fertility, measuring sperm DNA programming and functional quality — including the sperm's ability to find, bind, penetrate, and fertilize an egg, as well as its impact on embryo health and pregnancy success. Priced at $529 USD versus typical $700 in-clinic cost, with results returned within 3 weeks.
• Sapyen Complete Analysis Most comprehensive at-home male fertility test, bundling all core and advanced parameters (semen analysis, antisperm antibodies, DNA fragmentation, and DNA methylation) into a single kit for the most complete picture of sperm health. Priced at $869 USD versus typical $1,400 in-clinic costs.
• Post Vasectomy Semen Analysis (PVSA) At-home test confirming vasectomy success by checking semen for the presence of sperm. Recommended 12–16 weeks after surgery and after at least 20 ejaculations. Priced at $99 USD versus typical $200 in-clinic cost, with results within 3 working days. Targets post-vasectomy patients seeking procedure confirmation.
• Vasectomy Reversal Test At-home semen analysis test taken 6–8 weeks after vasectomy reversal surgery to determine whether sperm has returned and whether it is healthy enough for conception. Priced at $149 USD.
• Sapyen Cryopreservation (Sperm Freezing) At-home sperm cryopreservation service preserving sperm at -196°C for up to 6 years. The 90-day program includes 2 semen collection kits, a vitamin protocol, infectious disease screening, and 6 years of storage at FDA-registered facility (US) or HFEA-licensed center (UK). Initial storage fee of $1 for the first year; standard in-clinic costs run ~$800. Refund provided if sample cannot be frozen. 7-day free cancellation offered. Targets men delaying parenthood, those about to undergo treatments affecting fertility, and gender-affirming care patients.
• Full Female Blood Panel Female fertility blood panel testing AMH, FSH, LH, estradiol, testosterone, and prolactin levels to assess female reproductive health. Pairs with Sapyen's male tests for couples fertility assessment. Targets the female partners in couples undergoing fertility evaluation.
• Couples At-Home Fertility Testing Suite Combined at-home fertility testing suite offering both Sapyen's male fertility tests (incorporating the Core Semen Analysis and SPX72-preserved lab semen analysis) and the Full Female Blood Panel for couples simultaneously. Aims to reduce delays in fertility assessment for couples in the UK market by enabling both partners to be evaluated at home in parallel.

Quantifiable outcome

• 72-hour sample viability vs 60-90 minute industry standard
• +3 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability1 record

Feature3 records

Partnerships

Twelve partnerships are on record, tiered minor and core.

• Spermosens ABminorStrategic or Co-development Partner · 1 January 2025Spermosens AB signed Memoranda of Understanding with Sapyen and RSI Technology Group to advance partner-driven commercialization of male fertility diagnostics in global markets. The partnership aims to advance Spermosens' JUNO-Checked male fertility diagnostic technology through Sapyen's distribution network.
• Path FertilitycoreTechnology or IntegrationSapyen integrates Path Fertility's SpermQT epigenetic assay into its SpermEGT DNA Methylation Test, combining Sapyen's at-home collection and logistics with Path Fertility's specialized DNA methylation analysis technology.
• GeneacoreGTM or Marketing PartnerLeading Australian IVF clinic that refers patients to Sapyen and endorses the company's at-home testing services. Part of Sapyen's network of trusted clinic partners.
• No.1 FertilitycoreGTM or Marketing PartnerMajor fertility clinic network that recommends Sapyen testing to patients. Endorsed by clinic specialists including Eve Glage.
• IVIRMAcoreGTM or Marketing PartnerGlobal IVF clinic group referring patients to Sapyen for at-home male fertility testing. One of the world's leading fertility treatment networks.
• ProgynycoreGTM or Marketing PartnerLeading fertility benefit provider offering Sapyen tests at $0 cost to eligible members through employer benefit plans. Sapyen handles authorization and fulfillment for Progyny members.
• WIN FertilitycoreGTM or Marketing PartnerFertility benefit provider enabling eligible WIN Fertility members to order Sapyen test kits at no cost. Sapyen processes authorizations and ships kits on behalf of WIN Fertility.
• Carrot FertilityminorGTM or Marketing PartnerFertility benefit provider where Sapyen customers can purchase tests and submit for reimbursement through Carrot's platform.
• Maven ClinicminorGTM or Marketing PartnerFertility and family building benefit provider offering reimbursement for Sapyen tests. Customers purchase and submit invoices for reimbursement.
• Oxford UniversityminorStrategic or Co-development PartnerAcademic institution collaborating on research and development of Sapyen's testing technology and methodology. Part of development team including experts and researchers.
• Harvard UniversityminorStrategic or Co-development PartnerAcademic institution contributing to development of Sapyen's testing technology. Collaboration with fertility experts and researchers.
• Stanford UniversityminorStrategic or Co-development PartnerAcademic institution involved in development of Sapyen's testing methodology. Contributes expertise from fertility researchers.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Legacy: Legacy is a direct male fertility DTC company offering at-home sperm testing and cryopreservation, with a similar product-led go-to-market model and recurring storage revenue. Closely aligned business model, target customer, and product set as Sapyen.
• Dadi: Dadi offers at-home sperm testing and long-term storage with a kit + subscription model, competing in the same use cases (preconception testing and cryopreservation) and customer segments as Sapyen.
• Fellow: Fellow sells mail-in male fertility test kits with clinician-reviewed results and offers cryopreservation — overlapping head-to-head with Sapyen on product, customer (men planning families), and channel (DTC + clinician referrals).
• YO Home Sperm Test: YO is an FDA-cleared at-home male fertility test kit with smartphone-based motility analysis — same at-home, direct-to-consumer sperm testing category that Sapyen competes in.
• ExSeed Health: ExSeed provides at-home sperm analysis kits and lifestyle-focused male fertility programs in Europe; directly comparable as a mail-in semen analysis service targeting men trying to conceive.

Broad incumbents

• Maven Clinic: Maven is a leading family-building benefit provider; comparable to Sapyen in that it channels beneficiaries toward male fertility solutions and is also a Sapyen distribution partner, representing an incumbent in the fertility benefit category.
• Progyny: Progyny is a fertility benefit management incumbent that integrates with Sapyen for $0-copay male testing — comparable as the dominant employer-channel beneficiary of male fertility diagnostics and a key Sapyen channel partner.
• Carrot Fertility: Carrot is a global fertility benefit provider serving employers; comparable as a dominant incumbent in the channel through which male fertility products (including Sapyen's) are distributed and reimbursed.
• Ro (Roman): Ro is a broader men's and women's health platform with a fertility vertical offering sperm testing and treatments — comparable because it serves the same customer intent (male fertility evaluation) but as part of a much wider telehealth portfolio.

Regional players

• Genea Biomedx: Genea Biomedx develops fertility lab diagnostics and IVF lab technologies, primarily APAC-focused; comparable as a fertility diagnostics adjacent player closely tied to the same clinician network (Genea) that partners with Sapyen.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/sapyenco
• LinkedInlinkedin.com/company/sapyenco

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sapyen